glp-1 agonists marketing strategies 2025 Market Exclusive Research Report GLP-1 Receptor Agonist Market Size
Description
JAMA Health Forum 2 , e214182 (2021)
Long-term efficacy and safety of linagliptin in patients with type 2 diabetes and severe renal impairment: A 1-year, randomized, double-blind, placebo-controlled study
J Gastroenterol Hepatol
2024;16(9) doi: 10.7759/CUREUS.68390
